Envista Holdings (NVST) Share-based Compensation (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Share-based Compensation of $10.2 million in Q2 2026, down 1.92% quarter-over-quarter from $10.4 million in Q4 2025, and up 43.66% on a YoY basis from $7.1 million in Q2 2025.
Envista Holdings (NVST) Share-based Compensation (2018 - 2026) Analysis & Trends
Envista Holdings' Share-based Compensation history runs 9 years deep, the most recent figure standing at $10.2 million for Q2 2026.
- In Q2 2026, Share-based Compensation rose 43.66% year-over-year to $10.2 million; the TTM figure through Apr 2026 stood at $40.7 million (up 29.62% YoY), while the FY2025 annual figure was $37.6 million, up 6.52% from the prior year.
- Share-based Compensation was $10.2 million for Q2 2026 at Envista Holdings, down from $10.4 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $15.0 million in Q1 2023 to a low of $4.5 million in Q4 2023.
- Historically, Share-based Compensation has averaged $8.5 million across 5 years, with a median of $8.3 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation slumped 39.19% in 2023, then soared 104.44% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $7.4 million in 2022, then plunged by 39.19% to $4.5 million in 2023, then soared by 104.44% to $9.2 million in 2024, then increased by 13.04% to $10.4 million in 2025, then retreated by 1.92% to $10.2 million in 2026.
- The last three Share-based Compensation figures came in at $10.2 million (Q2 2026), $10.4 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 209.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 58.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 23.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 26.79 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 6.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 51.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 40.92 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 10.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | 10.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 10.20 Mn |
| Apr 3, 2026 | 10.20 Mn |
| Dec 31, 2025 | 10.40 Mn |
| Dec 31, 2025 | 10.40 Mn |
| Sep 26, 2025 | 10.40 Mn |
| Sep 26, 2025 | 10.40 Mn |
| Jun 27, 2025 | 9.70 Mn |
| Jun 27, 2025 | 9.70 Mn |
| Mar 28, 2025 | 7.10 Mn |
| Mar 28, 2025 | 7.10 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Sep 27, 2024 | 9.80 Mn |
| Sep 27, 2024 | 9.80 Mn |
| Jun 28, 2024 | 5.30 Mn |
| Jun 28, 2024 | 5.30 Mn |
| Mar 29, 2024 | 11.00 Mn |
| Mar 29, 2024 | 11.00 Mn |
| Dec 31, 2023 | 4.50 Mn |
| Dec 31, 2023 | 4.50 Mn |